NASDAQ
Inhibitor Therapeutics, Inc. (INTI) has a current ratio of 3.19x as of Monday, May 25, 2026. This represents a 67.42% decrease compared to its 12-month average of 9.80x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.